• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On July 21, Libang Pharmaceuticals-B (09637.HK) announced that its global Phase IIb multi-regional clinical trial of AP306 for the treatment of hyperphosphatemia in maintenance hemodialysis patients has completed the randomization and dosing of the first subject. The trial is being conducted at multiple clinical centers in the United States and China, and plans to recruit approximately 168 subjects. The primary results (topline data) are expected to be released in the first half of 2027.BAE Systems, Boeing (BA.N) and Saab have signed an agreement to advance cooperation on training UK pilots based on the Boeing T-7 system.German Chancellor Merz: Discussed gas and oil supply issues with the President of Azerbaijan.Eli Lilly (LLY.N) shares are down slightly in pre-market trading, currently down 0.58%.July 21 – Nuveen Global Investment Strategist Laura Cooper stated in a report that the European Central Bank (ECB) is likely to keep interest rates unchanged at its meeting this week after the June rate hike, but will maintain a tighter tone. Cooper said the ECB would remain open to further tightening if renewed tensions drive up energy prices. She said inflation is more moderate than feared, with little sign of renewed acceleration in the Purchasing Managers Index (PMI) pricing sub-index, while producer price data confirms that upstream cost pressures are easing. “These factors provide a reason to hold rates steady this month,” she said. The complexity lies in renewed disruptions to commodity supplies, which could reignite energy price pressures at a time when the ECB is gaining confidence in the path of declining inflation.

As the BoJ ponders a YCC expansion, EUR/JPY continues to decline, falling below 142.60

Alina Haynes

Apr 06, 2023 11:52

 EUR:JPY.png

 

After plunging below 142.60 during the Asian trading session, the EUR/JPY pair's three-day losing trend was extended. Renewed rumors of an expansion of the Bank of Japan's (BoJ) Yield Curve Control (YCC) are exerting immense pressure on the cross.

 

The Japanese economy is experiencing gradual wage growth, and inflation is expected to respond to recent increases in crude oil prices. Analysts at Wells Fargo believe the BoJ will take advantage of a tactical opportunity to further modify its policy settings in the fourth quarter of 2022, and are inclined toward a meeting in October. They added that this timeframe is optimal for a smooth policy adjustment, as monetary easing from the Federal Reserve (Fed) and other major central banks should alleviate yield pressure.

 

In particular, the Bank of Japan (BoJ) will raise the target yield for 10-year Japanese government bonds (JGBs) from 0% to 0.25% and increase the tolerance interval surrounding this target to +/- 75 basis points.

 

Accelerating PMIs in the Eurozone provide support for the European Central Bank's sustained rate hikes. (ECB). S&P Global reported a Composite PMI of 53.7 on Wednesday, which was higher than the previous release of 52.0 but below expectations of 54.1, the highest level in the past ten months.

 

According to Reuters, S&P Global issued the following statement: "Manufacturing production increased slightly, but the service sector had the greatest impact on March's accelerated growth."

 

Wednesday, ECB policymaker Boris Vuji stated regarding interest rate forecasts, "The majority of the rate-hiking cycle has passed." He added, "We may require additional rate increases to address core inflation."